Diabetes and Weight Loss Are Associated With Malignancies in Patients With Intraductal Papillary Mucinous Neoplasms.

Pergolini, I; Jäger, C; Safak, O; Göß, R; Novotny, A; Ceyhan, GÜRALP; Friess, H; Demir, IE

doi:10.1016/j.cgh.2020.04.090

Diabetes and Weight Loss Are Associated With Malignancies in Patients With Intraductal Papillary Mucinous Neoplasms.

Pergolini I., Jäger C., Safak O., Göß R., Novotny A., Ceyhan G., ...More

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol.19, pp.171-179, 2021 (SCI-Expanded)

Publication Type: Article / Article
Volume: 19
Publication Date: 2021
Doi Number: 10.1016/j.cgh.2020.04.090
Journal Name: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
Page Numbers: pp.171-179
Keywords: Metabolic Disorders, IPMN, Malignant Progression, RISK-FACTORS, PANCREAS, PROGRESSION, GUIDELINES, MANAGEMENT, PREDICTORS, DIAGNOSIS, MELLITUS, DUCT, IPMN
Acibadem Mehmet Ali Aydinlar University Affiliated: Yes

Abstract

BACKGROUND & AIMS: The role of diabetes in intraductal papillary mucinous neoplasms (IPMNs) is not known. We investigated the prevalence of diabetes among patients with resected IPMNs and the association between diabetes, clinical and morphological features, and high-grade dysplasia or invasive cancer.